{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:01:21Z","timestamp":1761562881486},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,10]]},"DOI":"10.7759\/cureus.24876","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T14:49:42Z","timestamp":1652194182000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Advanced Synchronous Primary Ovarian and Cervical Cancer"],"prefix":"10.7759","author":[{"given":"Mahmoud","family":"Abdelsamia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Mosalem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venumadhavi","family":"Gogineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerthi","family":"Gullapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eghosa","family":"Olomu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2006.09.010","article-title":"Clinical analysis of synchronous primary neoplasms of the female reproductive tract","volume":"136","author":"Tong SY","year":"2008","unstructured":"Tong SY, Lee YS, Park JS, Bae SN, Lee JM, Namkoong SE. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur J Obstet Gynecol Reprod Biol. 2008, 136:78-82. 10.1016\/j.ejogrb.2006.09.010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner SE","year":"2003","unstructured":"Waggoner SE. Cervical cancer. Lancet. 2003, 361:2217-25. 10.1016\/S0140-6736(03)13778-6","journal-title":"Lancet"},{"key":"ref3","article-title":"Multifocal disease in the upper genital canal","volume":"65","author":"Woodruff JD","year":"1985","unstructured":"Woodruff JD, Solomon D, Sullivant H. Multifocal disease in the upper genital canal. Obstet Gynecol. 1985, 65:695-8.","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04646-8","article-title":"Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England","volume":"357","author":"Sasieni P","year":"2001","unstructured":"Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001, 357:1490-3. 10.1016\/S0140-6736(00)04646-8","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2011.01261.x","article-title":"Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan","volume":"90","author":"Huang CY","year":"2011","unstructured":"Huang CY, You SL, Chen CJ, Cheng WF, Luo HC, Hsieh CY. Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan. Acta Obstet Gynecol Scand. 2011, 90:1342-9. 10.1111\/j.1600-0412.2011.01261.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2011.22.2.76","article-title":"Cervical cancer in the screening era: who fell victim in spite of successful screening programs?","volume":"22","author":"Pettersson BF","year":"2011","unstructured":"Pettersson BF, Hellman K, Vaziri R, Andersson S, Hellstr\u00f6m AC. Cervical cancer in the screening era: who fell victim in spite of successful screening programs?. J Gynecol Oncol. 2011, 22:76-82. 10.3802\/jgo.2011.22.2.76","journal-title":"J Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30152","article-title":"Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?","volume":"139","author":"Castanon A","year":"2016","unstructured":"Castanon A, Landy R, Sasieni PD. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?. Int J Cancer. 2016, 139:1040-5. 10.1002\/ijc.30152","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601754","article-title":"Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence","volume":"90","author":"Zappa M","year":"2004","unstructured":"Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer. 2004, 90:1784-6. 10.1038\/sj.bjc.6601754","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.172","article-title":"Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit","volume":"71","author":"Mitchell H","year":"1995","unstructured":"Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer. 1995, 71:894-7. 10.1038\/bjc.1995.172","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2012.01420.x","article-title":"Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma","volume":"91","author":"Chen JL","year":"2012","unstructured":"Chen JL, Cheng JC, Kuo SH, Chen CA, Lin MC, Huang CY. Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma. Acta Obstet Gynecol Scand. 2012, 91:1158-66. 10.1111\/j.1600-0412.2012.01420.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.049","article-title":"Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study","volume":"103","author":"Wang SS","year":"2006","unstructured":"Wang SS, Sherman ME, Silverberg SG, et al.. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol. 2006, 103:541-6. 10.1016\/j.ygyno.2006.03.049","journal-title":"Gynecol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11371","article-title":"Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma","volume":"97","author":"Farley JH","year":"2003","unstructured":"Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003, 97:2196-202. 10.1002\/cncr.11371","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)","volume":"390","author":"Tewari KS","year":"2017","unstructured":"Tewari KS, Sill MW, Penson RT, et al.. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017, 390:1654-63. 10.1016\/S0140-6736(17)31607-0","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle A","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, et al.. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2020, 38:1-10. 10.1200\/JCO.19.02105","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92163-a-rare-case-of-advanced-synchronous-primary-ovarian-and-cervical-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:39Z","timestamp":1707507699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92163-a-rare-case-of-advanced-synchronous-primary-ovarian-and-cervical-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.24876","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}